The numbers of e-scooter and e-bike injuries have tripled in the US since 2019, fuelled by alcohol and substance use, finds a nationwide analysis of emergency department visits, published online in the journal Injury Prevention.
Humira biosimilar launches may serve as a test case for wider investments, Biosimilars Forum leader cautions
Any comparisons between AbbVie’s multibillion-dollar-per-quarter Humira (adalimumab) and its biosimilar market, and the blockbuster insulins’ biosimilars market can simply point to the need for two